Skip To Main Content
Deze website is alleen bedoeld voor zorgverleners van België en Luxemburg.
Campus
  • Wetenschap
  • Artikelen
  • Opleiding
  • Andere onderwerpen
Campus
  • Wetenschap
  • Artikelen
  • Opleiding
  • Andere onderwerpen

Artikelen

Sort by

Filters

Resetten
  • Therapeutische gebieden

FLUNITY-HD : the largest individually randomised influenza vaccine effectiveness study of its kind.

FLUNITY-HD is the largest individually randomised influenza vaccine effectiveness study, with nearly half a million older adults across multiple seasons.1

Leer meer

Cumulative Life Course Impairment (CLCI) in Atopic Dermatitis

Leer meer

Deliver-T (RWE Study): New Findings on Toujeo® for T2D Management Following Dual GIP/GLP-1 RA Therapy

Leer meer

IL-4 and IL-13: centrale cytokines die type 2-inflammatie aansturen

Leer meer

Breaking the Barrier: How to Manage Hypoglycaemia Fear in Diabetes Care

Leer meer

Reframing the Insulin Conversation: Helping People With Type 2 Diabetes to Embrace Life

Leer meer

The story of the Beta Cells and their role in autoimmune Type 1 Diabetes

Leer meer

Defining ITP

Low platelet counts are one facet of ITP, but when we look at it from another angle, we see the multiple dimensions of ITP. ITP is a condition of complex immune dysregulation that reduces platelet counts—causing bleeding, bruising, fatigue, and other health-related quality-of-life (HRQoL) issues—while increasing inflammation and the risk of thromboembolic events (TEs).1-5

Leer meer

Living with ITP

Patients reported significant quality of life (QoL) challenges related to their ITP1

Leer meer

Assessing fatigue in ITP patients

For ITP patients, several scales are available to measure and track fatigue and its impact on quality of life. These tools can help patients and healthcare providers gauge symptoms and adjust their ITP treatment accordingly.1-4

Leer meer

Mechanism of Disease

Complex immune dysregulation can lead to autoimmunity and inflammation1-6

Leer meer

EVEREST study: First ever direct Head-to-Head Comparison of Dupilumab vs Omalizumab in Patients with Severe CRSwNP and Coexisting Asthma

First ever direct Head-to-Head Comparison of Dupilumab vs Omalizumab in Patients with Severe CRSwNP and Coexisting Asthma.

Leer meer